Medindia

X

Free Access to Taxotere Instills New Hope among Early Stage Breast Cancer Patients

by Medindia Content Team on  July 24, 2006 at 8:37 PM Cancer News   - G J E 4
Free Access to Taxotere Instills New Hope among Early Stage Breast Cancer Patients
National Institute for Health and Clinical Excellence said that 10,000 breast cancer patients who are in their early stage of the disease would be given free access to Taxotere, a chemotherapy drug.
Advertisement

This drug was initially given to those suffering from late-stage breast cancer. Statistics said that this initiative would save more than 600 lives of patients suffering from breast cancer. The guidance comes nine months after the Scottish equivalent of Nice, the Scottish Medicines Consortium, approved the use of Taxotere for Scottish women in the early stages of the disease.

Advertisement
David Miles, consultant oncologist at London Bridge hospital, said that this drug has the potential to prevent the deaths of hundreds of women with breast cancer. He said that this is an important step taken towards the treatment of early stage breast cancer in the UK. Numerous clinical trials confirm that Taxotere-containing regimens are very effective in the treatment of breast cancer. Hence from November every primary care trust will be obliged to offer the drug to breast cancer patients whose cancer has spread to their lymph nodes.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All